What is QTest Labs?
QTest Labs operates as a purpose-built Contract Research Organization (CRO) dedicated to bridging the gap between drug discovery and pre-clinical trials. The company specializes in enhancing the safety and efficacy of pharmaceuticals and medical devices, with a particular focus on cardiovascular safety and risk assessment. By employing advanced scientific methodologies and cutting-edge technology, QTest Labs aims to accelerate understanding of test articles, reduce lead times, and provide comprehensive research solutions that extend beyond conventional regulatory frameworks. Their services are designed for pharmaceutical and medical device firms seeking predictive efficacy and safety testing.
How much funding has QTest Labs raised?
QTest Labs has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
What's next for QTest Labs?
The substantial capital infusion, characterized as a large-scale late-stage funding event, positions QTest Labs for significant expansion and further technological advancement. This strategic backing is expected to fuel the company's efforts in refining its cardiovascular safety and risk assessment platforms, potentially enabling QTest Labs to broaden its service offerings and deepen its market penetration. The company's focus on predictive testing and mechanistic understanding suggests a strategic direction towards becoming a key partner for pharmaceutical and medical device innovators navigating complex pre-clinical development pathways.
See full QTest Labs company page
